β-Lactam Derivatives as Inhibitors of Human Cytomegalovirus Protease

The development of novel monobactam inhibitors of HCMV protease incorporating a carbon side chain at C-4 and a urea function at N-1 is described. Substitution with small groups at the C-3 position of the β-lactam ring gave an increase in enzymatic activity and in stability; however, a lack of select...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 41; no. 15; pp. 2882 - 2891
Main Authors Yoakim, Christiane, Ogilvie, William W, Cameron, Dale R, Chabot, Catherine, Guse, Ingrid, Haché, Bruno, Naud, Julie, O'Meara, Jeff A, Plante, Raymond, Déziel, Robert
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 16.07.1998
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The development of novel monobactam inhibitors of HCMV protease incorporating a carbon side chain at C-4 and a urea function at N-1 is described. Substitution with small groups at the C-3 position of the β-lactam ring gave an increase in enzymatic activity and in stability; however, a lack of selectivity against other serine proteases was noted. The use of both tri- and tetrasubstituted urea functionalities gave effective inhibitors of HCMV protease. Benzyl substitution of the urea moiety was beneficial, especially when strong electron-withdrawing groups where attached at the para position. Modest antiviral activity was found in a plaque reduction assay.
Bibliography:istex:DFB7D4FB6169E22FCD60E43CB6B0B78D91258225
ark:/67375/TPS-4FJ8JK84-M
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0022-2623
1520-4804
DOI:10.1021/jm980131z